Ovid Therapeutics Ownership | Who Owns Ovid Therapeutics?
Ovid Therapeutics Ownership Summary
Ovid Therapeutics is owned by 2877.10% institutional investors, 16.31% insiders. Takeda pharmaceutical is the largest institutional shareholder, holding 602.56% of OVID shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.52% of its assets in Ovid Therapeutics shares.
OVID Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ovid Therapeutics | 2877.10% | 16.31% | -2793.41% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Takeda pharmaceutical | 7.53M | 602.56% | $2.49M |
| Bvf inc/il | 3.85M | 308.31% | $1.27M |
| Sio capital management | 2.23M | 178.56% | $736.34K |
| Acadian asset management | 2.11M | 168.67% | $693.00K |
| Kennedy capital management | 1.50M | 120.19% | $495.62K |
| Driehaus capital management | 1.40M | 112.02% | $461.92K |
| Blackrock funding, inc. /de | 1.37M | 109.52% | $451.64K |
| Adage capital partners gp | 1.15M | 92.00% | $379.38K |
| Tls advisors | 680.97K | 54.48% | $225.00K |
| Affinity asset advisors | 667.52K | 53.40% | $220.21K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Takeda pharmaceutical | 7.53M | 12.71% | $2.49M |
| Tls advisors | 680.97K | 0.70% | $225.00K |
| Madison avenue partners, lp | 3.72M | 0.37% | $3.48M |
| Sio capital management | 2.23M | 0.28% | $736.34K |
| Rubric capital management lp | 5.32M | 0.06% | $4.96M |
| Velan capital investment management lp | 70.00K | 0.06% | $65.36K |
| Artal group | 2.50M | 0.05% | $1.92M |
| Bvf inc/il | 3.85M | 0.05% | $1.27M |
| Affinity asset advisors | 667.52K | 0.03% | $220.21K |
| Kennedy capital management | 1.50M | 0.01% | $495.62K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Assenagon asset management | 924.58K | 0.00% | 488.96K |
| State street | 1.35M | - | 198.72K |
| Marshall wace, llp | 164.72K | 0.00% | 164.72K |
| Y-intercept (hong kong) | 160.31K | 0.00% | 160.31K |
| Hrt financial lp | 123.32K | 0.00% | 97.72K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -6.12M |
| Siren | - | - | -2.85M |
| Blackrock funding, inc. /de | 1.37M | - | -2.49M |
| Ubs oconnor | - | - | -943.42K |
| Blue owl capital lp | - | - | -864.82K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Marshall wace, llp | 164.72K | 0.00% | 164.72K | $54.36K |
| Y-intercept (hong kong) | 160.31K | 0.00% | 160.31K | $52.88K |
| Qube research | 72.74K | - | 72.74K | $24.00K |
| Velan capital investment management lp | 70.00K | 0.06% | 70.00K | $65.36K |
| Susquehanna group, llp | 45.12K | - | 45.12K | $42.13K |
Sold Out
| Holder | Change |
|---|---|
| Newedge advisors | -4.00 |
| Advisor group | -5.00 |
| Ifp advisors | -8.00 |
| True wealth design | -8.00 |
| Nelson, van denburg & campbell wealth management group | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 69 | -15.85% | 35,963,757 | -7.47% | 2,877 | 297.56% | 34 | 17.24% | 21 | -25.00% |
| Mar 31, 2025 | 83 | - | 46,400,658 | -2.45% | 37 | 0.83% | 29 | -21.62% | 28 | 33.33% |
| Dec 31, 2024 | 28 | -63.16% | 10,144,389 | -73.85% | 14 | 0.48% | 13 | -69.05% | 7 | -53.33% |
| Sep 30, 2024 | 76 | 2.70% | 38,794,655 | 0.78% | 54 | 1.84% | 42 | 16.67% | 15 | -40.00% |
| Jun 30, 2024 | 74 | -8.64% | 38,492,740 | -9.60% | 54 | 1.50% | 36 | -5.26% | 25 | 4.17% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.79M | 2.52% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.75M | 2.47% | -38.35K |
| Kennedy Micro Cap | 1.04M | 1.46% | -64.12K |
| Fidelity Small Cap Index | 578.63K | 0.81% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 563.03K | 0.79% | -256.56K |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 525.80K | 0.74% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 525.80K | 0.74% | - |
| MEDICAL BioHealth EUR Acc | 503.85K | 0.71% | - |
| Kennedy Micro Cap Opportunities | 465.48K | 0.65% | 82.64K |
| iShares Biotechnology ETF | 393.77K | 0.55% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 26, 2025 | ALEXANDER MARGARET A. | President and COO | Sell | $2.96K |
| Feb 26, 2025 | Rona Jeffrey A | CBFO | Sell | $2.19K |
| Jan 27, 2025 | ALEXANDER MARGARET A. | President and COO | Buy | $4.97K |
| Mar 18, 2024 | LEVIN JEREMY M | CEO | Buy | $50.36K |
| Sep 12, 2022 | Tardio Jason | Chief Operating Officer | Sell | $37.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 1 | 2 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q1 | 1 | - |
| 2023 Q4 | - | - |
OVID Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools